Companies / Mexico
Elimination of Local Plant Requirement Provokes Opposition
July 2007 | Legal NewsMexico's Secretary of Economy has reportedly sent a draft decree to the federal body charged with improving regulation and trade policy that envisions a scrapping of Mexico's 'plant requirement' law, which currently requires manufacturers to have production and testing facilities in the country in order to import and market pharmaceuticals in the country. Such a step was previously advanced in guidance issued by the federal Commission for Regulatory Improvement (Cofemer). But local industry group, the Confederation of Industrial Chambers (Concamin), has charged that such a move would effectively cede large amounts of control over the quality of pharmaceuticals and other
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
